Precision pathology for cancer and kidney diseases using AI

Aiosyn Mitosis Breast leverages deep learning to detect cell division in whole slide images, enhancing the efficiency and consistency of mitosis analysis for breast cancer grading. The application integrates with existing digital pathology software and can be deployed via cloud-based or on-premise installations, ensuring adaptability to diverse laboratory environments.

We use science-based innovation to create AI-powered image analysis software, enhancing workflows and delivering certified solutions that have a positive impact on patients. Our computational pathology technology provides data-driven insights to improve clinical diagnostics and complement R&D studies.

By leveraging artificial intelligence (AI) to analyze whole slide images, our solutions can boost diagnostic accuracy and efficiency in digital pathology workflows.  

For biopharma organizations, AI offers the potential to simplify and accelerate drug discovery and development. 

Collaboration with pathologists is crucial in developing AI tools, as is understanding and supporting their tasks and processes. At Aiosyn, we provide precision pathology solutions that inject deep learning algorithms into existing workflows, equipping medical professionals and researchers with data-driven insights. Our close connection to clinical practice enables us to build these solutions for and together with pathology labs and biopharma companies.

By co-developing our technology with experts and integrating modular software into standard workflows, we facilitate the adoption of digital pathology AI in clinical practice to improve patient outcomes worldwide.